A large number of medicines can be reimbursed from next month

Starting from March 1, the 2020 National Medical Insurance Drug List was officially launched, and 119 new drugs were added to the list, with an average price reduction of 50.

Beijing: Improve the policy of special diseases in outpatient clinics, currently there are 17 kinds of diseases

It is reported that Beijing has included all the 119 drugs added by the state into the city's medical insurance drug list.

At the same time, the types of reimbursements for outpatient special diseases have also been adjusted and improved.

Guangdong: 17 new anticancer drugs added compared with last year

According to statistics, the new version of the Guangdong Medical Insurance Drug Catalog includes more than 3,100 types of Western medicines, Chinese patent medicines, and nationally negotiated medicines.

The new version of the medical insurance drug catalogue includes all the drugs listed in the latest version of the national new crown pneumonia diagnosis and treatment plan and 221 nationally negotiated drugs into the scope of medical insurance payment in Guangdong Province to help prevent and control the new crown pneumonia epidemic, and conduct national negotiations on cancer, mental illness, eye disease, and pediatrics.

The new version of the medical insurance drug catalog added 17 new anti-cancer drugs compared with last year, including new drugs such as lenvatinib; in 2018, the price of 14 exclusive drugs among the anti-cancer drugs negotiated by the state was further reduced, with an average drop of 14.

Hebei: The list of medical insurance drugs is 297 more than the national version

The 2020 Hebei Medical Insurance Catalogue contains a total of 3,097 drugs.

Among them, there are 2579 kinds of conventional drugs in the national catalogue; 221 kinds of drugs negotiated during the period of the national catalogue agreement; Hebei Province temporarily reserves 297 supplementary medicines.

In the field of anticancer drugs, the 17 oncology drugs negotiated by the state in 2018 will expire at the end of 2020.

At the same time, 17 new anti-cancer drugs were added in this adjustment, including PD-1, lenvatinib, etc.

Zhejiang: Improving outpatient insurance policies and opening medical insurance designated pharmacies

Starting from March 1, 2021, Zhejiang Basic Medical Insurance, Work Injury Insurance and Maternity Insurance will implement the "2020 Drug Catalog" uniformly.

When special medicines for critical illness insurance are transferred to this catalog, the state-restricted payment scope and payment standards shall be implemented simultaneously.

Zhejiang province-level recruitment and procurement departments must include the drugs in the "2020 Drug Catalog" into the scope of the provincial drug procurement platform.

Medical security departments at all levels should promote the implementation of the "2020 Drug Catalog" by improving outpatient insurance policies, opening medical insurance designated pharmacies, and rationally adjusting total control.

In addition, since March 1, Sichuan Province will fully implement the new version of medical insurance, and will include 12 negotiated drugs into the scope of medication for residents' diabetes outpatient clinics.

.

With the official launch of the National Medical Insurance Drug List in 2020, local supplementary products have also begun to withdraw, and a large number of drugs in various pharmacies withdraw from medical insurance and no longer reimburse.
.
.

These drugs can no longer be reimbursed

According to the "Notice of the Jiangsu Provincial Department of Human Resources and Social Security on the Publication of the First Batch of Digestible Lists of Provincial Supplementary Drugs for Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drugs" previously issued by the Jiangsu Provincial Medical Insurance Bureau, it is necessary to complete the three-year digestion of the provincial supplementary drugs.
Work, after data analysis and expert argumentation, the first batch of digestive list of supplementary drugs in the province is now announced.

This also means that 111 medicines including Fenghan Ganmao Ning Granules, Guiqi Granules, Xiaoshuan Oral Liquid, Weishuning Granules, Shiwei Xiaoshisan, Changyanning Syrup, Yupingfeng Pills (oral liquid), etc.
, have been transferred out of medical insurance.
No longer reimbursed.

It is reported that the types of medical insurance that have been transferred out include both chemical medicines and proprietary Chinese medicines.

Attached is the list of the first batch of drugs withdrawn from medical insurance in Jiangsu Province

According to incomplete statistics, with the support of policies, Jiangxi, Shandong, Beijing, Hunan, Sichuan, Guangdong, Tianjin, Zhejiang, Anhui, Guangxi and other provinces and cities have clearly issued documents on the elimination of supplements to the local medical insurance catalogue.
On the whole, the provinces are basically All have achieved the key monitoring products first to call out the medical insurance, but the specific product size and the corresponding time node are relatively different.

This also means that a large number of drugs will no longer be reimbursed for medical insurance in the future.
For the list of varieties transferred from each province, you can log in to the official website of the local medical insurance bureau for inquiries.